Page 37 - Read Online
P. 37

Dong et al. Neuroimmunol Neuroinflammation 2018;5:5  I  http://dx.doi.org/10.20517/2347-8659.2017.47                   Page 3 of 10


               in contrast to this inhibition. On the other hand, TDP 43 was also found to repress cryptic exon splicing
                                            [14]
               in order to promote cell survival . TDP-43-dependent splicing defects, revealing TDP-43 extensively
               regulated cryptic splicing, are a significant overlap in genes that undergo TDP-43-dependent cryptic splicing
                        [14]
               repression .

               THE ORIGIN OF PATHOLOGICAL TDP-43
               Pathological TDP-43 mediated neuronal death is mainly caused by neurotoxicity and loss of TDP-43
                       [17]
               function . Phosphorylation and ubiquitination of TDP-43, the major features of pathological TDP-43,
               have not been detected in the normal brain. Phosphorylated and/or ubiquitinated TDP-43 have been found
                                                          [4]
               in the brain and spinal cord of patients with ALS . In human studies, not all of TDP-43 inclusion bodies
               have been ubiquitinated, especially in the early stage of ALS, which suggests that ubiquitination is an
                                                          [18]
               advanced metabolic phenomenon in ALS disease . The phosphorylated TDP-43 exists more commonly
               with serine (Ser) 379, Ser 403 + Ser 404, Ser 409 +, and Ser 410, which mainly between Ser 409-410. Most of
               the inclusion bodies of TDP-43 and TDP-43 25-kDa, as the degradation fragments of TDP 43, are detected
                                      [4]
               in the phosphorylated form . Therefore, the process of phosphorylation is likely preceded by ubiquitination.
               However, it is still unclear which form plays a more determinant role in mediating TDP-43 induced
               neurodegeneration.

                                                                                                       [19]
               In pathological conditions, TDP-43 protein degrades into two degradation fragments at the C-terminal .
               By selectively expressing mutations in neurons and glial cells, the pathological TDP-43 protein is more
               commonly found to concentrate in neuronal cells, which may cause it failure to regulate synaptic plasticity
               and neuronal death [8,20] . Thus, mistakenly accumulated TDP-43 in motor neurons might be the initial
                                    [20]
               mechanism of ALS onset .
               The fragments of TDP-43 protein can induce TDP-43 deposition, which is related to the ubiquitin
               proteasome system [5,21] . The overexpression of the full-length protein of TDP-43 and its aggregation can be
               detected in high expression of tardbp CTFs cells. Although both TDP-43 and TDP-43 fragments would be
               affected by the ubiquitin proteasome system, CTFs fragments are more likely to foster transcription without
               stopping due to the absence of two nuclear localization signals. In addition, Cdc48TS, as an enhancer of
                                                                      [22]
               neurotoxicity, promotes the deposition of pathological TDP-43 . Thus, any influence on the ubiquitin
               proteasome system may increase the expression of ubiquitination of TDP-43.



               PATHOGENESIS OF TDP-43
               In Drosophila motor neurons, the high expression of TDP-43 caused axonal swelling and impaired
                                                                                                    [23]
               mobility. Moreover, impairment was more severe in the motor neurons of A315T mutant phenotype . The
               TDP-43 peptide segments can form in vitro in both the wild-type and A315T mutant, which are misfolded
                                                              [23]
               like precipitation as seen using an electron microscope . Therefore, the main pathogenesis of ALS may be
               caused by the abnormal accumulation of TDP-43 in motor neurons and secondary atrophy of neurons or
               glial cells.

               According to the findings in polymerization kinetics study, the pathological C terminus had a prion-like
               domain structure. This prion domain is present in most of the pathogenic mutations of TDP-43 [23,24] . The
               pathological C terminus is intrinsically disordered only with some nascent secondary structures in aqueous
               solutions, but processes the capacity to assemble into dynamic oligomers rich in b-sheet structures. There
                                                                                         [25]
               structures interact with nucleic acid, which triggers rapid aggregation for most mutants . Although RNA-
               binding protein prion-like domains have no homology or sequence similarity to the human prion protein
               that forms infectious protein aggregates in new variant Creutzfeldt-Jakob disease, many of these proteins
               have been identified as the major components of cytoplasmic inclusions associated with subtypes of ALS and
   32   33   34   35   36   37   38   39   40   41   42